These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 14562398)

  • 21. Anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies as predictors of inflammatory bowel disease.
    Israeli E; Grotto I; Gilburd B; Balicer RD; Goldin E; Wiik A; Shoenfeld Y
    Gut; 2005 Sep; 54(9):1232-6. PubMed ID: 16099791
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases.
    Muratori P; Muratori L; Guidi M; Maccariello S; Pappas G; Ferrari R; Gionchetti P; Campieri M; Bianchi FB
    Clin Exp Immunol; 2003 Jun; 132(3):473-6. PubMed ID: 12780695
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment and relevance of enzyme-linked immunosorbent assay for antibodies to Saccharomyces cerevisiae in Australian patients with inflammatory bowel disease.
    Moore MM; Fabricatorian D; Selby WS
    Intern Med J; 2002 Jul; 32(7):349-52. PubMed ID: 12088356
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostic role of anti-saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease].
    Gao X; Hu PJ; He Y; Liao SY; Peng S; Chen MH
    Zhonghua Nei Ke Za Zhi; 2005 Jun; 44(6):428-30. PubMed ID: 16008854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of serological markers to differentiate between ulcerative colitis and Crohn's disease: pANCA, ASCA and agglutinating antibodies to anaerobic coccoid rods.
    Linskens RK; Mallant-Hent RC; Groothuismink ZM; Bakker-Jonges LE; van de Merwe JP; Hooijkaas H; von Blomberg BM; Meuwissen SG
    Eur J Gastroenterol Hepatol; 2002 Sep; 14(9):1013-8. PubMed ID: 12352222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical utility of serological markers in inflammatory bowel disease.
    Mokrowiecka A; Daniel P; Słomka M; Majak P; Malecka-Panas E
    Hepatogastroenterology; 2009; 56(89):162-6. PubMed ID: 19453050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-Saccharomyces cerevisiae antibody titres correlate well with disease activity in children with Crohn's disease.
    El-Matary W; Dupuis K; Sokoro A
    Acta Paediatr; 2015 Aug; 104(8):827-30. PubMed ID: 25877674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Anti-Saccharomyces cerevisiae antibody does not differentiate between Crohn's disease and intestinal tuberculosis.
    Makharia GK; Sachdev V; Gupta R; Lal S; Pandey RM
    Dig Dis Sci; 2007 Jan; 52(1):33-9. PubMed ID: 17160471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antibodies to Saccharomyces cerevisiae: are they useful in clinical practice?
    Candelli M; Papa A; Nista EC; Danese S; Armuzzi A; Bartolozzi F; Tondi P; Ojetti V; Gasbarrini G; Gasbarrini A
    Hepatogastroenterology; 2003; 50(51):718-20. PubMed ID: 12828069
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The prevalence and diagnostic value of perinuclear antineutrophil cytoplasmic antibodies and anti-Saccharomyces cerevisiae antibodies in patients with inflammatory bowel disease in mainland China.
    Zhou F; Xia B; Wang F; Shrestha UK; Chen M; Wang H; Shi X; Chen Z; Li J
    Clin Chim Acta; 2010 Oct; 411(19-20):1461-5. PubMed ID: 20570669
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease.
    Peeters M; Joossens S; Vermeire S; Vlietinck R; Bossuyt X; Rutgeerts P
    Am J Gastroenterol; 2001 Mar; 96(3):730-4. PubMed ID: 11280542
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of serologic disease markers in a population-based cohort of patients with ulcerative colitis and Crohn's disease.
    Sandborn WJ; Loftus EV; Colombel JF; Fleming KA; Seibold F; Homburger HA; Sendid B; Chapman RW; Tremaine WJ; Kaul DK; Wallace J; Harmsen WS; Zinsmeister AR; Targan SR
    Inflamm Bowel Dis; 2001 Aug; 7(3):192-201. PubMed ID: 11515844
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antineutrophil cytoplasmic autoantibodies and anti-Saccharomyces cerevisiae antibodies in inflammatory bowel diseases.
    Kiliç ZM; Tunç B; Ayaz S; Filik L; Aktaş S; Parlak E; Ulker A
    Turk J Gastroenterol; 2004 Dec; 15(4):238-42. PubMed ID: 16249978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. pANCA and ASCA in the diagnosis of different subtypes of inflammatory bowel disease.
    Mokrowiecka A; Gasiorowska A; Malecka-Panas E
    Hepatogastroenterology; 2007; 54(77):1443-8. PubMed ID: 17708273
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uric acid levels are independent of anti-Saccharomyces cerevisiae antibodies (ASCA) in Crohn's disease: A reappraisal of the role of S. cerevisiae in this setting.
    Sendid B; Jawhara S; Sarter H; Maboudou P; Thierny C; Gower-Rousseau C; Colombel JF; Poulain D
    Virulence; 2018; 9(1):1224-1229. PubMed ID: 30027793
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparison of five techniques to detect anti-Saccharomyces cerevisiae antibodies (ASCA) in serum for diagnosing Crohn's disease].
    Le Goff C; Chapelle JP; Lutteri L
    Ann Biol Clin (Paris); 2007; 65(6):601-8. PubMed ID: 18039604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
    Dendrinos KG; Becker JM; Stucchi AF; Saubermann LJ; LaMorte W; Farraye FA
    J Gastrointest Surg; 2006; 10(7):1060-4. PubMed ID: 16843878
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Partial overlap of anti-mycobacterial, and anti-Saccharomyces cerevisiae mannan antibodies in Crohn's disease.
    Müller S; Schaffer T; Schoepfer AM; Hilty A; Bodmer T; Seibold F
    World J Gastroenterol; 2008 Jun; 14(23):3650-61. PubMed ID: 18595132
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Marker antibody expression stratifies Crohn's disease into immunologically homogeneous subgroups with distinct clinical characteristics.
    Vasiliauskas EA; Kam LY; Karp LC; Gaiennie J; Yang H; Targan SR
    Gut; 2000 Oct; 47(4):487-96. PubMed ID: 10986208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disappearance of anti-Saccharomyces cerevisiae antibodies in coeliac disease during a gluten-free diet.
    Mallant-Hent RCh; Mary B; von Blomberg E; Yüksel Z; Wahab PJ; Gundy C; Meyer GA; Mulder CJ
    Eur J Gastroenterol Hepatol; 2006 Jan; 18(1):75-8. PubMed ID: 16357623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.